Last --
Change Today 0.00 / 0.00%
Volume 0.0
All times are local (Market data is delayed by at least 15 minutes).

obj ltd (OBJLF) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
0.0
EPS TTM
--
Shares Outstanding
1.5B
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for OBJ LTD (OBJLF)

Related News

No related news articles were found.

obj ltd (OBJLF) Related Businessweek News

No Related Businessweek News Found

obj ltd (OBJLF) Details

OBJ Limited develops magnetic, micro-array drug and ingredient delivery technologies for use in pharmaceutical, cosmetic and skincare, and consumer healthcare industries in Australia. It offers various technology platforms, including Static Micro-arrays, a film based micro-array technology for patches, masks, dressings, and other topical applications; Field in Motion Micro-arrays, a magnetic micro-array film for use in brushes, applicators, and wipes; and Dermaportation, a technology platform that enables a range of commercial applications. The company also provides eSkin, a multi-product delivery system, which offers a range of product-specific, time-varying magnetic fields for enhanced delivery of multiple formulations; measured dose delivery devices and packaging solutions; and BodyGuard, a suite of active patch products designed for the restoration and treatment of joint pain and degeneration. OBJ Limited is based in Leederville, Australia.

obj ltd (OBJLF) Top Compensated Officers

Chief Scientist, Technical Director and Execu...
Total Annual Compensation: A$247.0K
International Partnering Manager
Total Annual Compensation: A$226.9K
Compensation as of Fiscal Year 2014.

obj ltd (OBJLF) Key Developments

OBJ Limited Launch of SK-II Product in South Korea

OBJ Limited reported the successful professional, media and consumer launch of the commercial product to incorporate OBJ's propriety magnetic micro-array technology. The product launch by SK-II, released to the public the magnetic micro-array 'Wand' in the form of the SK-II Magnetic Eye Care Kit.

OBJ Limited Reports Unaudited Consolidated Earnings Results for the Year Ended June 30, 2014

OBJ Limited reported unaudited consolidated earnings results for the year ended June 30, 2014. For the year, revenue was AUD 950,857 against AUD 786,014 a year ago. Loss before tax was AUD 2,205,354 against AUD 1,331,572 a year ago. Loss attributable to members of the company was AUD 2,205,354 or 0.16 cents per basic and diluted share against AUD 1,331,572 or 0.11 cents per basic and diluted share a year ago. Net cash used in operating activities was AUD 1,847,969 against AUD 1,265,967 a year ago.

OBJ Limited and P&G Sign Multi-Product Development Agreement and Initial Licensing Agreement

OBJ Limited announced that OBJ and Procter and Gamble have entered into a suite of agreements including a multi-product development agreement (PDA) and an initial licensing agreement (initial licence) that sets the course to commercialize OBJ's magnetic micro-array technology. The PDA, initial license and associated product development work plans comprise a multi-product, multi-category program that grants P&G world-wide exclusive access to OBJ's non- powered micro- array technology in specific consumer product categories. The agreement package includes the over-arching multi-product and multi-category PDA, the key terms of the master license that will apply to all new products developed under the PDA and work plans for the development of the first three products to utilize OBJ's magnetic micro-array technology, which includes the initial license for the first of these products. More specifically, the agreement package includes: The multi- product, multi category PDA which covers 7 of P&G's major product categories. The key terms, together with a term sheet for the principal business terms, of an overarching licensing agreement that will be applied to all new products developed under the PDA. The initial license containing the principal business terms of a licensing agreement, and product development work plan, for the first product to utilize OBJ's non-powered magnetic micro-array technology. Minimum funding levels (including by R&D investment) required to maintain exclusivity rights in certain product categories. Three funded work plans for products to be developed under the PDA. Royalty payments payable to OBJ on further licensed products.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
OBJLF:US $0.00 USD 0.00

OBJLF Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for OBJLF.
View Industry Companies
 

Industry Analysis

OBJLF

Industry Average

Valuation OBJLF Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 135.9x
Price/Book 32.7x
Price/Cash Flow NM Not Meaningful
TEV/Sales 132.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact OBJ LTD, please visit www.obj.com.au. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.